Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

68 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.
Boehm T, Folkman J, Browder T, O'Reilly MS. Boehm T, et al. Nature. 1997 Nov 27;390(6658):404-7. doi: 10.1038/37126. Nature. 1997. PMID: 9389480
Angiostatin inhibits and regresses corneal neovascularization.
Ambati BK, Joussen AM, Ambati J, Moromizato Y, Guha C, Javaherian K, Gillies S, O'Reilly MS, Adamis AP. Ambati BK, et al. Arch Ophthalmol. 2002 Aug;120(8):1063-8. doi: 10.1001/archopht.120.8.1063. Arch Ophthalmol. 2002. PMID: 12149060
Regulation of angiostatin mobilization by tumor-derived matrix metalloproteinase-2.
Moses MA, O'Reilly MS. Moses MA, et al. Methods Mol Med. 2003;74:375-90. doi: 10.1385/1-59259-323-2:375. Methods Mol Med. 2003. PMID: 12415709 No abstract available.
Inhibition of tumor growth by plasminogen-related protein-B.
Lewis VO, O'Reilly MS, Gehrmann M, Llinás M, Schaller J, Weissbach L. Lewis VO, et al. Anticancer Res. 2001 Jul-Aug;21(4A):2287-91. Anticancer Res. 2001. PMID: 11724284
Radiation therapy to a primary tumor accelerates metastatic growth in mice.
Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O'Reilly MS. Camphausen K, et al. Cancer Res. 2001 Mar 1;61(5):2207-11. Cancer Res. 2001. PMID: 11280788
A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
Sim BK, O'Reilly MS, Liang H, Fortier AH, He W, Madsen JW, Lapcevich R, Nacy CA. Sim BK, et al. Cancer Res. 1997 Apr 1;57(7):1329-34. Cancer Res. 1997. PMID: 9102221
Suppression of tumor growth with recombinant murine angiostatin.
Wu Z, O'Reilly MS, Folkman J, Shing Y. Wu Z, et al. Biochem Biophys Res Commun. 1997 Jul 30;236(3):651-4. doi: 10.1006/bbrc.1997.7032. Biochem Biophys Res Commun. 1997. PMID: 9245707
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.
Browder T, Butterfield CE, Kräling BM, Shi B, Marshall B, O'Reilly MS, Folkman J. Browder T, et al. Cancer Res. 2000 Apr 1;60(7):1878-86. Cancer Res. 2000. PMID: 10766175
Antiangiogenic activity of the cleaved conformation of the serpin antithrombin.
O'Reilly MS, Pirie-Shepherd S, Lane WS, Folkman J. O'Reilly MS, et al. Science. 1999 Sep 17;285(5435):1926-8. doi: 10.1126/science.285.5435.1926. Science. 1999. PMID: 10489375
Zinc-binding of endostatin is essential for its antiangiogenic activity.
Boehm T, O'reilly MS, Keough K, Shiloach J, Shapiro R, Folkman J. Boehm T, et al. Biochem Biophys Res Commun. 1998 Nov 9;252(1):190-4. doi: 10.1006/bbrc.1998.9617. Biochem Biophys Res Commun. 1998. PMID: 9813168
68 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback